Biogen, Eisai Alzheimer’s drug review delayed in EU
Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) are expected to face another delay in launching their new Alzheimer's drug, lecanemab, in the EU after the European Commission on Friday asked the region's ...
JD Supra17h
Main strategic lines of the new Competitiveness Compass for the EU
The European Commission has published on the 29th January the “Competitiveness Compass for the EU”, setting out ambitious initiatives aimed ...
BusinessWorld1d
France, Germany, others urge EC to protect elections in Europe from foreign interference
France, Germany, and 10 other European Union (EU) countries want the European Commission (EC) to use its powers under the Digital Services Act to protect the integrity of European elections from ...
Hosted on MSN2d
EU proposes new tariffs on Russian imports to curb reliance
On Tuesday evening, the European Commission adopted a proposal to impose tariffs on a range of agricultural products from ...